Loading resource…

William R. Kirchain and Bobby LeDuff II
The document is part of DiPiro's Pharmacotherapy Handbook, 13th Edition, and focuses on the Roussel-Uclaf Causality Assessment Method (RUCAM) for evaluating drug-induced liver injury. It includes tables that outline criteria for assessment and relative patterns of hepatic enzyme elevation associated with different types of hepatic lesions. This resource is essential for understanding the implications of drug therapy on liver health.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

INTERPRETING ABNORMAL LIVER BLOOD TEST RESULTS
Same clinical topic · Hepatology

UGANDA GUIDELINES FOR PREVENTION, TESTING, CARE AND TREATMENT OF HEPATITIS B AND C VIRUS INFECTION
Same specialty · Hepatology

Hepatitis E Virus, Second Edition (Springer, 2023)
Same specialty · Hepatology

metabolic liver disease, PBC and PSC charles
Same specialty · Hepatology

EASL Clinical Practice Guidelines on Vascular Diseases of the Liver
Same specialty · Hepatology

AUTOIMMUNE HEPATITIS
Same specialty · Hepatology

MOLECULAR MECHANISMS AND PATHOGENESIS OF MASH
Same specialty · Hepatology

CIRRHOSIS, PORTAL HYPERTENSION AND HEPATOCELLULAR CARCINOMA: A STAGE-BASED APPROACH
Same specialty · Hepatology

NEW APPROACHES TO CHRONIC HEPATITIS B
Same specialty · Hepatology